Doxorubicin/eribulinLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2025年 / 2044卷 / 1期

关键词：

D O I：

10.1007/s40278-025-75796-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：130 / 130

相关论文

共 50 条

[41] Docetaxel/doxorubicin/gemcitabineLack of efficacy: case report
Reactions Weekly, 2020, 1834 (1) : 101 - 101
[42] Doxorubicin/pazopanibLack of efficacy and mania: case report
Reactions Weekly, 2023, 1950 (1) : 173 - 173
[43] Cyclophosphamide/doxorubicin/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1871 (1) : 136 - 136
[44] Dacarbazine/doxorubicin/sunitinibLack of efficacy: case report
Reactions Weekly, 2022, 1927 (1) : 212 - 212
[45] Doxorubicin/ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2024, 2030 (1) : 171 - 171
[46] Bevacizumab/doxorubicin liposomalLack of efficacy: case report
Reactions Weekly, 2020, 1833 (1) : 100 - 100
[47] Doxorubicin/ifosfamide/mesnaLack of efficacy : case report
Reactions Weekly, 2023, 1949 (1) : 187 - 187
[48] Dacarbazine/doxorubicin/vinblastineLack of efficacy: case report
Reactions Weekly, 2022, 1902 (1) : 163 - 163
[49] Doxorubicin/ifosfamideAlveolopleural fistula and lack of efficacy: case report
Reactions Weekly, 2023, 1972 (1) : 150 - 150
[50] Doxorubicin/paclitaxelCardiac failure and lack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 209 - 209

← 1 2 3 4 5 →